首页> 外文期刊>Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment >Use of a thrombin-gelatin matrix for hemostasis after failed device closure of femoral arterial access
【24h】

Use of a thrombin-gelatin matrix for hemostasis after failed device closure of femoral arterial access

机译:股动脉通路装置关闭失败后,凝血酶-明胶基质用于止血的应用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Access and closure continue to be a source of complications for all arterial endovascular procedures. Despite significant developments made in vascular closure devices (VCD), failure to achieve hemostasis in a small proportion of cases leads to continued bleeding, necessitating prolonged compression or surgical repair for larger punctures. We report on the use of a thrombin-gelatin matrix (Floseal, Baxter, Hayward, CA) to achieve hemostasis in two patients, in whom device closure failed to control arterial bleeding after femoral arterial access.
机译:进入和闭合仍然是所有动脉血管内手术并发症的来源。尽管在血管闭合装置(VCD)方面已取得了重大进展,但在少数情况下未能实现止血会导致持续的出血,需要延长压缩时间或进行较大穿刺的手术修复。我们报道了使用凝血酶-明胶基质(Floseal,Baxter,Hayward,CA)在两名患者中实现止血,其中装置闭合无法控制股动脉进入后的动脉出血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号